{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T17:19:02Z","timestamp":1793726342054,"version":"4.6.1"},"reference-count":275,"publisher":"MDPI AG","issue":"7","license":[{"start":{"date-parts":[[2020,7,5]],"date-time":"2020-07-05T00:00:00Z","timestamp":1593907200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Toxins"],"abstract":"<jats:p>Cardiovascular disease and infections are major causes for the high incidence of morbidity and mortality of patients with chronic kidney disease. Both complications are directly or indirectly associated with disturbed functions or altered apoptotic rates of polymorphonuclear leukocytes, monocytes, lymphocytes, and dendritic cells. Normal responses of immune cells can be reduced, leading to infectious diseases or pre-activated\/primed, giving rise to inflammation and subsequently to cardiovascular disease. This review summarizes the impact of kidney dysfunction on the immune system. Renal failure results in disturbed renal metabolic activities with reduced renin, erythropoietin, and vitamin D production, which adversely affects the immune system. Decreased kidney function also leads to reduced glomerular filtration and the retention of uremic toxins. A large number of uremic toxins with detrimental effects on immune cells have been identified. Besides small water-soluble and protein-bound compounds originating from the intestinal microbiome, several molecules in the middle molecular range, e.g., immunoglobulin light chains, retinol-binding protein, the neuropeptides Met-enkephalin and neuropeptide Y, endothelin-1, and the adipokines leptin and resistin, adversely affect immune cells. Posttranslational modifications such as carbamoylation, advanced glycation products, and oxidative modifications contribute to uremic toxicity. Furthermore, high-density lipoprotein from uremic patients has an altered protein profile and thereby loses its anti-inflammatory properties.<\/jats:p>","DOI":"10.3390\/toxins12070439","type":"journal-article","created":{"date-parts":[[2020,7,6]],"date-time":"2020-07-06T11:07:42Z","timestamp":1594033662000},"page":"439","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":161,"title":["Immune Dysfunction in Uremia 2020"],"prefix":"10.3390","volume":"12","author":[{"given":"Gerald","family":"Cohen","sequence":"first","affiliation":[{"name":"Department of Nephrology and Dialysis, Medical University of Vienna, Vienna A-1090, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2020,7,5]]},"reference":[{"key":"ref_1","unstructured":"Zemaitis, M.R., Foris, L.A., Chandra, S., and Bashir, K. (2020). Uremia, StatPearls."},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"(2013). Chapter 1: Definition and classification of CKD. Kidney Int. Suppl., 3, 19\u201362.","DOI":"10.1038\/kisup.2012.64"},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Hill, N.R., Fatoba, S.T., Oke, J.L., Hirst, J.A., O\u2019Callaghan, C.A., Lasserson, D.S., and Hobbs, F.D. (2016). Global Prevalence of Chronic Kidney Disease\u2014A Systematic Review and Meta-Analysis. PLoS ONE, 11.","DOI":"10.1371\/journal.pone.0158765"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1016\/S0140-6736(16)32064-5","article-title":"Chronic Kidney Disease","volume":"389","author":"Webster","year":"2017","journal-title":"Lancet"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1161\/CIRCULATIONAHA.119.042864","article-title":"Time Trends in Cardiovascular Disease Mortality Across the BRICS: An Age-Period-Cohort Analysis of Key Nations With Emerging Economies Using the Global Burden of Disease Study 2017","volume":"141","author":"Zou","year":"2020","journal-title":"Circulation"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/S0140-6736(13)60595-4","article-title":"Chronic kidney disease and cardiovascular risk: Epidemiology, mechanisms, and prevention","volume":"382","author":"Gansevoort","year":"2013","journal-title":"Lancet"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.2215\/CJN.00950208","article-title":"Aspects of immune dysfunction in end-stage renal disease","volume":"3","author":"Kato","year":"2008","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"2034","DOI":"10.1681\/ASN.2005101085","article-title":"Chronic kidney disease and mortality risk: A systematic review","volume":"17","author":"Tonelli","year":"2006","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_9","first-page":"382","article-title":"Malignant tumors in patients with end stage renal failure undergoing renal replacement therapy","volume":"16","author":"Kade","year":"2012","journal-title":"Contemp. Oncol. (Pozn)"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"66601","DOI":"10.18632\/oncotarget.18094","article-title":"Cancer and the kidney: Dangereoux liasons or price paid for the progress in medicine?","volume":"8","author":"Malyszko","year":"2017","journal-title":"Oncotarget"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S0140-6736(99)06154-1","article-title":"Cancer in patients on dialysis for end-stage renal disease: An international collaborative study","volume":"354","author":"Maisonneuve","year":"1999","journal-title":"Lancet"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"2504","DOI":"10.1681\/ASN.2014070714","article-title":"Cause of Death in Patients with Reduced Kidney Function","volume":"26","author":"Thompson","year":"2015","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"19","DOI":"10.5527\/wjn.v4.i1.19","article-title":"Aging and uremia: Is there cellular and molecular crossover?","volume":"4","author":"White","year":"2015","journal-title":"World J. Nephrol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1093\/ndt\/gfs451","article-title":"Out of control: Accelerated aging in uremia","volume":"28","author":"Kooman","year":"2013","journal-title":"Nephrol. Dial. Transplant."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1007\/s10741-014-9460-9","article-title":"Chronic kidney disease and cardiovascular complications","volume":"20","author":"House","year":"2015","journal-title":"Heart Fail. Rev."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1159\/000194455","article-title":"Increased Cardiovascular Risk Associated with Reduced Kidney Function","volume":"29","author":"Ryan","year":"2009","journal-title":"Am. J. Nephrol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"iii28","DOI":"10.1093\/ndt\/gfy174","article-title":"Cardiovascular disease in dialysis patients","volume":"33","author":"Cozzolino","year":"2018","journal-title":"Nephrol. Dial. Transplant."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1758","DOI":"10.1111\/j.1523-1755.2000.00337.x","article-title":"Mortality caused by sepsis in patients with end-stage renal disease compared with the general population","volume":"58","author":"Sarnak","year":"2000","journal-title":"Kidney Int."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"10539","DOI":"10.1038\/srep10539","article-title":"Chronic kidney disease is associated with a higher 90-day mortality than other chronic medical conditions in patients with sepsis","volume":"5","author":"Mansur","year":"2015","journal-title":"Sci. Rep."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1046\/j.1523-1755.1999.0550031081.x","article-title":"Septicemia in dialysis patients: Incidence, risk factors, and prognosis","volume":"55","author":"Powe","year":"1999","journal-title":"Kidney Int."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"2333","DOI":"10.1001\/archinte.168.21.2333","article-title":"Risk of bloodstream infection in patients with chronic kidney disease not treated with dialysis","volume":"168","author":"James","year":"2008","journal-title":"Arch. Intern. Med."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1111\/j.1525-139X.2007.00283.x","article-title":"Disturbances of acquired immunity in hemodialysis patients","volume":"20","author":"Eleftheriadis","year":"2007","journal-title":"Semin. Dial."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1038\/nri3523","article-title":"The immune system and kidney disease: Basic concepts and clinical implications","volume":"13","author":"Kurts","year":"2013","journal-title":"Nat. Rev. Immunol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"3431","DOI":"10.1182\/blood-2016-03-700336","article-title":"Human neutrophil kinetics: Modeling of stable isotope labeling data supports short blood neutrophil half-lives","volume":"127","author":"Elemans","year":"2016","journal-title":"Blood"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1038\/nri3399","article-title":"Neutrophil recruitment and function in health and inflammation","volume":"13","author":"Kolaczkowska","year":"2013","journal-title":"Nat. Rev. Immunol."},{"key":"ref_26","first-page":"192","article-title":"Dysfunction of polymorphonuclear leukocytes in uremia","volume":"16","year":"1996","journal-title":"Semin. Nephrol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1111\/j.1525-139X.2006.00175.x","article-title":"Neutrophil dysfunction and infection risk in end-stage renal disease","volume":"19","author":"Chonchol","year":"2006","journal-title":"Semin. Dial."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"8415179","DOI":"10.1155\/2017\/8415179","article-title":"Increased Neutrophil Extracellular Trap Formation in Uremia Is Associated with Chronic Inflammation and Prevalent Coronary Artery Disease","volume":"2017","author":"Kim","year":"2017","journal-title":"J. Immunol. Res."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/j.it.2011.04.009","article-title":"Neutrophil clearance: When the party is over, clean-up begins","volume":"32","author":"Bratton","year":"2011","journal-title":"Trends Immunol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1002\/jcb.22351","article-title":"Neutrophil apoptosis: A target for enhancing the resolution of inflammation","volume":"108","author":"Filep","year":"2009","journal-title":"J. Cell Biochem."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1159\/000421464","article-title":"Calcium-dependent neutrophil activation","volume":"100","year":"1992","journal-title":"Contrib. Nephrol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1038\/ki.1995.240","article-title":"Verapamil reverses abnormal [Ca2+]i and carbohydrate metabolism of PMNL of dialysis patients","volume":"47","author":"Mai","year":"1995","journal-title":"Kidney Int."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1159\/000056132","article-title":"Thapsigargin-induced calcium entry and apoptotic death of neutrophils are blocked by activation of protein kinase C","volume":"63","author":"Lucas","year":"2001","journal-title":"Pharmacology"},{"key":"ref_34","first-page":"359","article-title":"The relationship between fMLP induced neutrophil respiratory burst and the apoptosis of neutrophil","volume":"32","author":"Hu","year":"1999","journal-title":"Shi Yan Sheng Wu Xue Bao"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1681\/ASN.V871091","article-title":"Neutrophil superoxide release is required for spontaneous and FMLP-mediated but not for TNF alpha-mediated apoptosis","volume":"8","author":"Kettritz","year":"1997","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"2512","DOI":"10.1093\/ndt\/gfn098","article-title":"The uraemic retention solute para-hydroxy-hippuric acid attenuates apoptosis of polymorphonuclear leukocytes from healthy subjects but not from haemodialysis patients","volume":"23","author":"Cohen","year":"2008","journal-title":"Nephrol. Dial. Transplant."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"S195","DOI":"10.1046\/j.1523-1755.2001.59780195.x","article-title":"Dysfunction of polymorphonuclear leukocytes in uremia: Role of parathyroid hormone","volume":"78","author":"Massry","year":"2001","journal-title":"Kidney Int. Suppl."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1002\/JLB.3RU0719-241R","article-title":"Calcium signaling and regulation of neutrophil functions: Still a long way to go","volume":"107","author":"Hann","year":"2020","journal-title":"J. Leukoc. Biol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"277","DOI":"10.18388\/abp.2013_1983","article-title":"Neutrophil extracellular traps (NETs)\u2014formation and implications","volume":"60","author":"Zawrotniak","year":"2013","journal-title":"Acta Biochim. Pol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/j.it.2009.07.011","article-title":"NETs: A new strategy for using old weapons","volume":"30","author":"Papayannopoulos","year":"2009","journal-title":"Trends Immunol."},{"key":"ref_41","first-page":"4604713","article-title":"How Neutrophil Extracellular Traps Become Visible","volume":"2016","year":"2016","journal-title":"J. Immunol. Res."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"108263","DOI":"10.1016\/j.clim.2019.108263","article-title":"Prognostic role of circulating neutrophil extracellular traps levels for long-term mortality in new end-stage renal disease patients","volume":"210","author":"Kim","year":"2019","journal-title":"Clin. Immunol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1007\/s00011-016-1010-6","article-title":"NETosis provides the link between activation of neutrophils on hemodialysis membrane and comorbidities in dialyzed patients","volume":"66","author":"Korabecna","year":"2017","journal-title":"Inflamm. Res."},{"key":"ref_44","first-page":"428","article-title":"NETs: The missing link between cell death and systemic autoimmune diseases?","volume":"3","author":"Darrah","year":"2012","journal-title":"Front. Immunol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1089\/152308602753625870","article-title":"Neutrophil priming in host defense: Role of oxidants as priming agents","volume":"4","author":"Swain","year":"2002","journal-title":"Antioxid. Redox Signal."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"e12967","DOI":"10.1111\/eci.12967","article-title":"Priming and de-priming of neutrophil responses in vitro and in vivo","volume":"48","author":"Vogt","year":"2018","journal-title":"Eur. J. Clin. Invest."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/S0272-6386(99)70185-X","article-title":"Transplantation, not dialysis, corrects azotemia-dependent priming of the neutrophil oxidative burst","volume":"33","author":"Klein","year":"1999","journal-title":"Am. J. Kidney Dis."},{"key":"ref_48","first-page":"68","article-title":"The function and fate of neutrophils at the inflamed site: Prospects for therapeutic intervention","volume":"34","author":"Chilvers","year":"2000","journal-title":"J. R. Coll. Physicians Lond."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1111\/imr.12447","article-title":"Priming of the neutrophil respiratory burst: Role in host defense and inflammation","volume":"273","author":"Marzaioli","year":"2016","journal-title":"Immunol. Rev."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"2431","DOI":"10.1681\/ASN.2004110929","article-title":"Primed peripheral polymorphonuclear leukocyte: A culprit underlying chronic low-grade inflammation and systemic oxidative stress in chronic kidney disease","volume":"16","author":"Sela","year":"2005","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_51","doi-asserted-by":"crossref","unstructured":"Girndt, M., Trojanowicz, B., and Ulrich, C. (2020). Monocytes in Uremia. Toxins (Basel), 12.","DOI":"10.3390\/toxins12050340"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"1070959","DOI":"10.1155\/2017\/1070959","article-title":"Proportions of Proinflammatory Monocytes Are Important Predictors of Mortality Risk in Hemodialysis Patients","volume":"2017","author":"Jeng","year":"2017","journal-title":"Mediators Inflamm."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1093\/ndt\/gfl519","article-title":"Functional impairment of monocyte-derived dendritic cells in patients with severe chronic kidney disease","volume":"22","author":"Verkade","year":"2007","journal-title":"Nephrol. Dial. Transplant."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"152","DOI":"10.4110\/in.2017.17.3.152","article-title":"Dendritic Cell Dysfunction in Patients with End-stage Renal Disease","volume":"17","author":"Kim","year":"2017","journal-title":"Immune Netw."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"2185","DOI":"10.1093\/ndt\/gfu076","article-title":"Dendritic cells in progressive renal disease: Some answers, many questions","volume":"29","author":"Kitching","year":"2014","journal-title":"Nephrol. Dial. Transplant."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s00109-009-0541-5","article-title":"T cell cross-talk with kidney dendritic cells in glomerulonephritis","volume":"88","author":"Panzer","year":"2010","journal-title":"J. Mol. Med."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1038\/nrneph.2013.44","article-title":"Immune cell dysfunction and inflammation in end-stage renal disease","volume":"9","author":"Betjes","year":"2013","journal-title":"Nat. Rev. Nephrol."},{"key":"ref_58","doi-asserted-by":"crossref","unstructured":"Betjes, M.G. (2020). Uremia-Associated Ageing of the Thymus and Adaptive Immune Responses. Toxins (Basel), 12.","DOI":"10.3390\/toxins12040224"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1093\/ndt\/gfp397","article-title":"Effect of end-stage renal disease on B-lymphocyte subpopulations, IL-7, BAFF and BAFF receptor expression","volume":"25","author":"Pahl","year":"2010","journal-title":"Nephrol. Dial. Transplant."},{"key":"ref_60","doi-asserted-by":"crossref","unstructured":"Duni, A., Liakopoulos, V., Roumeliotis, S., Peschos, D., and Dounousi, E. (2019). Oxidative Stress in the Pathogenesis and Evolution of Chronic Kidney Disease: Untangling Ariadne\u2019s Thread. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20153711"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1053\/j.ajkd.2006.08.015","article-title":"Oxidative stress is progressively enhanced with advancing stages of CKD","volume":"48","author":"Dounousi","year":"2006","journal-title":"Am. J. Kidney Dis."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1159\/000501300","article-title":"Markers of Oxidative Stress and Endothelial Dysfunction Predict Haemodialysis Patients Survival","volume":"50","author":"Suvakov","year":"2019","journal-title":"Am. J. Nephrol."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"S109","DOI":"10.1046\/j.1523-1755.61.s80.20.x","article-title":"Oxidative stress in hemodialysis patients: Is NADPH oxidase complex the culprit?","volume":"61","author":"Morena","year":"2002","journal-title":"Kidney Int. Suppl."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1016\/j.clinbiochem.2011.06.988","article-title":"Oxidative stress and inflammation: Implications in uremia and hemodialysis","volume":"44","author":"Libetta","year":"2011","journal-title":"Clin. Biochem."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1093\/ndt\/gfh271","article-title":"Methylglyoxal: A stimulus to neutrophil oxygen radical production in chronic renal failure?","volume":"19","author":"Ward","year":"2004","journal-title":"Nephrol. Dial. Transplant."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"2559","DOI":"10.1681\/ASN.2013080906","article-title":"Integrative biology identifies shared transcriptional networks in CKD","volume":"25","author":"Martini","year":"2014","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_67","doi-asserted-by":"crossref","unstructured":"Jerotic, D., Matic, M., Suvakov, S., Vucicevic, K., Damjanovic, T., Savic-Radojevic, A., Pljesa-Ercegovac, M., Coric, V., Stefanovic, A., and Ivanisevic, J. (2019). Association of Nrf2, SOD2 and GPX1 Polymorphisms with Biomarkers of Oxidative Distress and Survival in End-Stage Renal Disease Patients. Toxins (Basel), 11.","DOI":"10.3390\/toxins11070431"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"S274","DOI":"10.1681\/ASN.2006080926","article-title":"Inflammatory syndrome in patients on hemodialysis","volume":"17","author":"Jofre","year":"2006","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"2613","DOI":"10.1093\/ndt\/gfm227","article-title":"Neutrophils in acidotic haemodialysed patients have lower intracellular pH and inflamed state","volume":"22","author":"Wann","year":"2007","journal-title":"Nephrol. Dial. Transplant."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1042\/CS20171459","article-title":"A causal link between oxidative stress and inflammation in cardiovascular and renal complications of diabetes","volume":"132","author":"Jha","year":"2018","journal-title":"Clin. Sci. (Lond.)"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/S0140-6736(13)60687-X","article-title":"Chronic kidney disease: Global dimension and perspectives","volume":"382","author":"Jha","year":"2013","journal-title":"Lancet"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1016\/j.kint.2016.09.010","article-title":"Management of patients with diabetes and CKD: Conclusions from a \u201cKidney Disease: Improving Global Outcomes\u201d (KDIGO) Controversies Conference","volume":"90","author":"Perkovic","year":"2016","journal-title":"Kidney Int."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1159\/000479256","article-title":"Inflammation and Protein-Energy Wasting in the Uremic Milieu","volume":"191","author":"Jankowska","year":"2017","journal-title":"Contrib Nephrol"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"lii","DOI":"10.1097\/01.MAT.0000147958.87989.EB","article-title":"Chronic systemic inflammation in dialysis patients: An update on causes and consequences","volume":"50","author":"Yao","year":"2004","journal-title":"Asaio J."},{"key":"ref_75","first-page":"59","article-title":"Cardiovascular risk factors in hemodialysis and peritoneal dialysis patients","volume":"21","author":"Helal","year":"2010","journal-title":"Saudi J. Kidney Dis. Transpl."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1038\/nrneph.2014.91","article-title":"Pattern recognition receptors and the inflammasome in kidney disease","volume":"10","author":"Leemans","year":"2014","journal-title":"Nat. Rev. Nephrol."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/j.cell.2010.01.022","article-title":"Pattern recognition receptors and inflammation","volume":"140","author":"Takeuchi","year":"2010","journal-title":"Cell"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1159\/000276764","article-title":"Leukocyte Toll-Like Receptor Expression in End-Stage Kidney Disease","volume":"31","author":"Gollapudi","year":"2010","journal-title":"Am. J. Nephrol."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"168","DOI":"10.5114\/ceji.2018.77387","article-title":"Basic inflammatory indices and chosen neutrophil receptors expression in chronic haemodialysed patients","volume":"43","author":"Baj","year":"2018","journal-title":"Cent. Eur. J. Immunol."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"2857","DOI":"10.4049\/jimmunol.1301539","article-title":"Processes of sterile inflammation","volume":"191","author":"Shen","year":"2013","journal-title":"J. Immunol."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1038\/s41581-019-0158-z","article-title":"The role of inflammasomes in kidney disease","volume":"15","author":"Komada","year":"2019","journal-title":"Nat. Rev. Nephrol."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1038\/nri.2016.58","article-title":"Inflammasomes: Mechanism of assembly, regulation and signalling","volume":"16","author":"Broz","year":"2016","journal-title":"Nat. Rev. Immuno.l"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1038\/ki.2013.336","article-title":"Volume overload correlates with cardiovascular risk factors in patients with chronic kidney disease","volume":"85","author":"Hung","year":"2014","journal-title":"Kidney Int."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"2491","DOI":"10.1681\/ASN.2016121341","article-title":"Chronic Fluid Overload and Mortality in ESRD","volume":"28","author":"Zoccali","year":"2017","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1159\/000485153","article-title":"Fluid Overload and Inflammation Axis","volume":"45","author":"Dekker","year":"2018","journal-title":"Blood Purif."},{"key":"ref_86","doi-asserted-by":"crossref","unstructured":"Ulrich, C., Wilke, A., Schleicher, N., Girndt, M., and Fiedler, R. (2020). Hypervolemia-Induced Immune Disturbances Do Not Involve IL-1ss but IL-6 and IL-10 Activation in Haemodialysis Patients. Toxins (Basel), 12.","DOI":"10.3390\/toxins12030159"},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1016\/j.cell.2011.10.026","article-title":"Autophagy: Renovation of cells and tissues","volume":"147","author":"Mizushima","year":"2011","journal-title":"Cell"},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.clim.2018.10.003","article-title":"The relationship between autophagy, increased neutrophil extracellular traps formation and endothelial dysfunction in chronic kidney disease","volume":"197","author":"Kim","year":"2018","journal-title":"Clin. Immunol."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1172\/JCI73945","article-title":"Immunologic manifestations of autophagy","volume":"125","author":"Deretic","year":"2015","journal-title":"J. Clin. Invest."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1038\/nature09663","article-title":"A role for mitochondria in NLRP3 inflammasome activation","volume":"469","author":"Zhou","year":"2011","journal-title":"Nature"},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1038\/ni.2215","article-title":"Activation of autophagy by inflammatory signals limits IL-1beta production by targeting ubiquitinated inflammasomes for destruction","volume":"13","author":"Shi","year":"2012","journal-title":"Nat. Immunol."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1038\/nature17950","article-title":"Noncanonical autophagy inhibits the autoinflammatory, lupus-like response to dying cells","volume":"533","author":"Martinez","year":"2016","journal-title":"Nature"},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1126\/science.1136880","article-title":"Autophagy-dependent viral recognition by plasmacytoid dendritic cells","volume":"315","author":"Lee","year":"2007","journal-title":"Science"},{"key":"ref_94","doi-asserted-by":"crossref","unstructured":"Lin, T.A., Wu, V.C., and Wang, C.Y. (2019). Autophagy in Chronic Kidney Diseases. Cells, 8.","DOI":"10.3390\/cells8010061"},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1038\/nrneph.2014.201","article-title":"Mechanisms and biological functions of autophagy in diseased and ageing kidneys","volume":"11","author":"Fougeray","year":"2015","journal-title":"Nat. Rev. Nephrol."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"426","DOI":"10.4161\/auto.19258","article-title":"Autophagic proteins: New facets of the oxygen paradox","volume":"8","author":"Jin","year":"2012","journal-title":"Autophagy"},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1159\/000356212","article-title":"Impaired leukocytes autophagy in chronic kidney disease patients","volume":"3","author":"Chen","year":"2013","journal-title":"Cardiorenal. Med."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"1832","DOI":"10.3389\/fimmu.2017.01832","article-title":"Autophagy: A Potential Therapeutic Target for Reversing Sepsis-Induced Immunosuppression","volume":"8","author":"Ren","year":"2017","journal-title":"Front. Immunol."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1111\/cei.13119","article-title":"The role of the immune system in kidney disease","volume":"192","author":"Tecklenborg","year":"2018","journal-title":"Clin. Exp. Immunol."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"156","DOI":"10.7861\/clinmed.2019-0452","article-title":"The role of complement in kidney disease","volume":"20","author":"Willows","year":"2020","journal-title":"Clin. Med. (Lond.)"},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.ekir.2016.08.015","article-title":"Complement Activation Induces Neutrophil Adhesion and Neutrophil-Platelet Aggregate Formation on Vascular Endothelial Cells","volume":"2","author":"Riedl","year":"2017","journal-title":"Kidney Int. Rep."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1053\/j.ajkd.2014.06.035","article-title":"Complement in kidney disease: Core curriculum 2015","volume":"65","author":"Thurman","year":"2015","journal-title":"Am. J. Kidney Dis."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.semnephrol.2013.08.005","article-title":"The role of the complement system in acute kidney injury","volume":"33","author":"McCullough","year":"2013","journal-title":"Semin. Nephrol."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"734","DOI":"10.3389\/fimmu.2020.00734","article-title":"Inflammaging and Complement System: A Link Between Acute Kidney Injury and Chronic Graft Damage","volume":"11","author":"Franzin","year":"2020","journal-title":"Front. Immunol."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1093\/ndt\/gfz036","article-title":"Interaction between inflammation, mineral metabolism and the renin-angiotensin system: Implications for cardiorenal outcomes in chronic kidney disease","volume":"34","year":"2019","journal-title":"Nephrol. Dial. Transplant."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1681\/ASN.2016101066","article-title":"Immunologic Effects of the Renin-Angiotensin System","volume":"28","author":"Crowley","year":"2017","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_107","first-page":"287","article-title":"Monocytic angiotensin-converting enzyme 2 relates to atherosclerosis in patients with chronic kidney disease","volume":"32","author":"Trojanowicz","year":"2017","journal-title":"Nephrol. Dial. Transplant."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1093\/ndt\/gfl008","article-title":"Increased expression of monocytic angiotensin-converting enzyme in dialysis patients with cardiovascular disease","volume":"21","author":"Ulrich","year":"2006","journal-title":"Nephrol. Dial. Transplant."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1159\/000493805","article-title":"Circulating miR-421 Targeting Leucocytic Angiotensin Converting Enzyme 2 Is Elevated in Patients with Chronic Kidney Disease","volume":"141","author":"Trojanowicz","year":"2019","journal-title":"Nephron"},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1681\/ASN.2006070707","article-title":"Human T and natural killer cells possess a functional renin-angiotensin system: Further mechanisms of angiotensin II-induced inflammation","volume":"18","author":"Jurewicz","year":"2007","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1182\/blood-2002-09-2785","article-title":"Oxidative stress is a critical mediator of the angiotensin II signal in human neutrophils: Involvement of mitogen-activated protein kinase, calcineurin, and the transcription factor NF-kappaB","volume":"102","author":"Alvarez","year":"2003","journal-title":"Blood"},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1681\/ASN.2014030240","article-title":"When erythropoietin meddles in immune affairs","volume":"25","author":"Martinez","year":"2014","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"2123","DOI":"10.1007\/s00467-018-4016-1","article-title":"Response to erythropoietin in pediatric patients with chronic kidney disease: Insights from an in vitro bioassay","volume":"33","author":"Gavish","year":"2018","journal-title":"Pediatr. Nephrol."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1056\/NEJM198701083160203","article-title":"Correction of the anemia of end-stage renal disease with recombinant human erythropoietin. Results of a combined phase I and II clinical trial","volume":"316","author":"Eschbach","year":"1987","journal-title":"N. Engl. J. Med."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1093\/ndt\/17.suppl_11.39","article-title":"Erythropoietin resistance: The role of inflammation and pro-inflammatory cytokines","volume":"17","author":"Macdougall","year":"2002","journal-title":"Nephrol. Dial. Transplant."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"S125","DOI":"10.1046\/j.1523-1755.1999.055Suppl.69125.x","article-title":"Iron and infection","volume":"69","author":"Patruta","year":"1999","journal-title":"Kidney Int. Suppl."},{"key":"ref_117","doi-asserted-by":"crossref","unstructured":"Yen, C.L., Lin, Y.S., Lu, Y.A., Lee, H.F., Lee, C.C., Tung, Y.C., Kuo, G., Wu, L.S., Tian, Y.C., and Chu, P.H. (2019). Intravenous iron supplementation does not increase infectious disease risk in hemodialysis patients: A nationwide cohort-based case-crossover study. BMC Nephrol., 20.","DOI":"10.1186\/s12882-019-1495-7"},{"key":"ref_118","first-page":"208","article-title":"Erythropoietin as an Immunomodulating Agent","volume":"3","author":"Lisowska","year":"2011","journal-title":"Nephro-Urol Mon."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1159\/000045991","article-title":"The polymorphonuclear leukocyte--a new target for erythropoietin","volume":"88","author":"Sela","year":"2001","journal-title":"Nephron"},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1111\/j.1525-1594.2009.00948.x","article-title":"Erythropoietin receptor is expressed on human peripheral blood T and B lymphocytes and monocytes and is modulated by recombinant human erythropoietin treatment","volume":"34","author":"Lisowska","year":"2010","journal-title":"Artif. Organs"},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1111\/j.1365-2249.2011.04417.x","article-title":"Erythropoietin enhances immunostimulatory properties of immature dendritic cells","volume":"165","author":"Rocchetta","year":"2011","journal-title":"Clin. Exp. Immunol."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1681\/ASN.2013090945","article-title":"Immunosuppressive effects of erythropoietin on human alloreactive T cells","volume":"25","author":"Cravedi","year":"2014","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_123","doi-asserted-by":"crossref","unstructured":"Begum, S., and Latunde-Dada, G.O. (2019). Anemia of Inflammation with An Emphasis on Chronic Kidney Disease. Nutrients, 11.","DOI":"10.3390\/nu11102424"},{"key":"ref_124","first-page":"25","article-title":"Hepcidin the link between inflammation and anemia in chronic renal failure","volume":"44","author":"Atanasiu","year":"2006","journal-title":"Rom. J. Intern. Med."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1111\/j.1365-2362.2006.01633.x","article-title":"New insights into the regulation of iron homeostasis","volume":"36","author":"Deicher","year":"2006","journal-title":"Eur. J. Clin. Invest."},{"key":"ref_126","first-page":"1170","article-title":"Hepcidin: A key regulator of iron","volume":"69","author":"Saneela","year":"2019","journal-title":"J. Pak. Med. Assoc."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1038\/ki.2009.21","article-title":"Plasma hepcidin levels are elevated but responsive to erythropoietin therapy in renal disease","volume":"75","author":"Ashby","year":"2009","journal-title":"Kidney Int."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"4260","DOI":"10.1038\/s41598-017-04664-y","article-title":"Serum hepcidin may be a novel uremic toxin, which might be related to erythropoietin resistance","volume":"7","author":"Lee","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1159\/000187089","article-title":"25-Hydroxyvitamin D3 metabolism in vitro by mononuclear cells from hemodialysis patients","volume":"62","author":"Reichel","year":"1992","journal-title":"Nephron"},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1093\/ndt\/15.suppl_5.18","article-title":"Management of disturbed calcium metabolism in uraemic patients: 1. Use of vitamin D metabolites","volume":"15","author":"Schomig","year":"2000","journal-title":"Nephrol. Dial. Transplant."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"S182","DOI":"10.1046\/j.1523-1755.2001.59780182.x","article-title":"Blunted response to vitamin D in uremia","volume":"78","author":"Glorieux","year":"2001","journal-title":"Kidney Int Suppl"},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"105456","DOI":"10.1155\/2014\/105456","article-title":"Vitamin D and the Immune System from the Nephrologist\u2019s Viewpoint","volume":"2014","author":"Lang","year":"2014","journal-title":"ISRN Endocrinol."},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"2167","DOI":"10.1007\/s00467-011-2071-y","article-title":"Can vitamin D slow down the progression of chronic kidney disease?","volume":"27","author":"Shroff","year":"2011","journal-title":"Pediatr. Nephrol."},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1210\/me.2011-1329","article-title":"Vitamin d receptor signaling inhibits atherosclerosis in mice","volume":"26","author":"Szeto","year":"2012","journal-title":"Mol. Endocrinol."},{"key":"ref_135","doi-asserted-by":"crossref","unstructured":"Carvalho, J.T.G., Schneider, M., Cuppari, L., Grabulosa, C.C., Danilo, T.A., Redublo, B.M.Q., Marcelo, C.B., Cendoroglo, M., Maria Moyses, R., and Dalboni, M.A. (2017). Cholecalciferol decreases inflammation and improves vitamin D regulatory enzymes in lymphocytes in the uremic environment: A randomized controlled pilot trial. PLoS ONE, 12.","DOI":"10.1371\/journal.pone.0179540"},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"2509","DOI":"10.1007\/s00467-018-4088-y","article-title":"Vitamin D and cardiovascular disease in chronic kidney disease","volume":"34","author":"Kaur","year":"2019","journal-title":"Pediatr. Nephrol."},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/978-1-4614-0887-1_8","article-title":"FGF23 in chronic kidney disease","volume":"728","author":"Wahl","year":"2012","journal-title":"Adv. Exp. Med. Biol."},{"key":"ref_138","doi-asserted-by":"crossref","unstructured":"Vogt, I., Haffner, D., and Leifheit-Nestler, M. (2019). FGF23 and Phosphate-Cardiovascular Toxins in CKD. Toxins (Basel), 11.","DOI":"10.3390\/toxins11110647"},{"key":"ref_139","doi-asserted-by":"crossref","unstructured":"Czaya, B., and Faul, C. (2019). The Role of Fibroblast Growth Factor 23 in Inflammation and Anemia. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20174195"},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1681\/ASN.2017070772","article-title":"Longitudinal FGF23 Trajectories and Mortality in Patients with CKD","volume":"29","author":"Isakova","year":"2018","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_141","first-page":"1566","article-title":"Prognostic value of bone- and vascular-derived molecular biomarkers in hemodialysis and renal transplant patients: A systematic review and meta-analysis","volume":"32","author":"Pichler","year":"2017","journal-title":"Nephrol. Dial. Transplant."},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1007\/s00774-019-01027-7","article-title":"Circulating FGF23 is not associated with cardiac dysfunction, atherosclerosis, infection or inflammation in hemodialysis patients","volume":"38","author":"Takashi","year":"2020","journal-title":"J Bone Miner. Metab."},{"key":"ref_143","doi-asserted-by":"crossref","unstructured":"Memmos, E., Sarafidis, P., Pateinakis, P., Tsiantoulas, A., Faitatzidou, D., Giamalis, P., Vasilikos, V., and Papagianni, A. (2019). Soluble Klotho is associated with mortality and cardiovascular events in hemodialysis. BMC Nephrol., 20.","DOI":"10.1186\/s12882-019-1391-1"},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"2132","DOI":"10.2215\/CJN.04260413","article-title":"CKD-mineral and bone disorder and risk of death and cardiovascular hospitalization in patients on hemodialysis","volume":"8","author":"Block","year":"2013","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"ref_145","doi-asserted-by":"crossref","unstructured":"Duque, E.J., Elias, R.M., and Moyses, R.M.A. (2020). Parathyroid Hormone: A Uremic Toxin. Toxins (Basel), 12.","DOI":"10.3390\/toxins12030189"},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1111\/j.1365-2796.2005.01508.x","article-title":"Impact of parathyroidectomy on neutrophil cytosolic calcium in chronic kidney disease patients: A prospective parallel group trial","volume":"258","author":"Deicher","year":"2005","journal-title":"J. Intern. Med."},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"S186","DOI":"10.1046\/j.1523-1755.2001.59780186.x","article-title":"Defects in B-cell function and metabolism in uremia: Role of parathyroid hormone","volume":"78","author":"Smogorzewski","year":"2001","journal-title":"Kidney Int. Suppl."},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1081\/JDI-56616","article-title":"Cellular immunity and levels of parathyroid hormone in uremic patients receiving hemodialysis","volume":"27","author":"Griveas","year":"2005","journal-title":"Ren. Fail."},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1177\/039139880102401004","article-title":"Uremic toxicity: Present state of the art","volume":"24","author":"Vanholder","year":"2001","journal-title":"Int. J. Artif. Organs"},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"1934","DOI":"10.1046\/j.1523-1755.2003.00924.x","article-title":"Review on uremic toxins: Classification, concentration, and interindividual variability","volume":"63","author":"Vanholder","year":"2003","journal-title":"Kidney Int."},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1681\/ASN.2011121175","article-title":"Normal and pathologic concentrations of uremic toxins","volume":"23","author":"Duranton","year":"2012","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1159\/000245639","article-title":"The gut: The forgotten organ in uremia?","volume":"29","author":"Schepers","year":"2010","journal-title":"Blood Purif."},{"key":"ref_153","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.semnephrol.2014.02.012","article-title":"Nonextracorporeal methods for decreasing uremic solute concentration: A future way to go?","volume":"34","author":"Meijers","year":"2014","journal-title":"Semin. Nephrol."},{"key":"ref_154","doi-asserted-by":"crossref","unstructured":"Glorieux, G., Gryp, T., and Perna, A. (2020). Gut-Derived Metabolites and Their Role in Immune Dysfunction in Chronic Kidney Disease. Toxins (Basel), 12.","DOI":"10.3390\/toxins12040245"},{"key":"ref_155","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1007\/s40620-019-00589-z","article-title":"The role of the intestinal microbiota in uremic solute accumulation: A focus on sulfur compounds","volume":"32","author":"Perna","year":"2019","journal-title":"J. Nephrol."},{"key":"ref_156","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1038\/nature11551","article-title":"Reciprocal interactions of the intestinal microbiota and immune system","volume":"489","author":"Maynard","year":"2012","journal-title":"Nature"},{"key":"ref_157","doi-asserted-by":"crossref","unstructured":"Wang, X., Yang, S., Li, S., Zhao, L., Hao, Y., Qin, J., Zhang, L., Zhang, C., Bian, W., and Zuo, L. (2020). Aberrant gut microbiota alters host metabolome and impacts renal failure in humans and rodents. Gut.","DOI":"10.1136\/gutjnl-2019-319766"},{"key":"ref_158","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1053\/j.ajkd.2015.09.027","article-title":"Role of the Gut Microbiome in Uremia: A Potential Therapeutic Target","volume":"67","author":"Ramezani","year":"2016","journal-title":"Am. J. Kidney Dis."},{"key":"ref_159","doi-asserted-by":"crossref","unstructured":"Popkov, V.A., Silachev, D.N., Zalevsky, A.O., Zorov, D.B., and Plotnikov, E.Y. (2019). Mitochondria as a Source and a Target for Uremic Toxins. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20123094"},{"key":"ref_160","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/s11255-012-0258-1","article-title":"An update on uremic toxins","volume":"45","author":"Neirynck","year":"2013","journal-title":"Int. Urol. Nephrol."},{"key":"ref_161","doi-asserted-by":"crossref","unstructured":"Vanholder, R., Pletinck, A., Schepers, E., and Glorieux, G. (2018). Biochemical and Clinical Impact of Organic Uremic Retention Solutes: A Comprehensive Update. Toxins (Basel), 10.","DOI":"10.3390\/toxins10010033"},{"key":"ref_162","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/s40620-015-0195-z","article-title":"Association of advanced age with concentrations of uraemic toxins in CKD","volume":"29","author":"Rroji","year":"2016","journal-title":"J. Nephrol."},{"key":"ref_163","doi-asserted-by":"crossref","unstructured":"Espi, M., Koppe, L., Fouque, D., and Thaunat, O. (2020). Chronic Kidney Disease-Associated Immune Dysfunctions: Impact of Protein-Bound Uremic Retention Solutes on Immune Cells. Toxins (Basel), 12.","DOI":"10.3390\/toxins12050300"},{"key":"ref_164","doi-asserted-by":"crossref","first-page":"3057","DOI":"10.1038\/s41598-017-03130-z","article-title":"Indoxyl sulfate (IS)-mediated immune dysfunction provokes endothelial damage in patients with end-stage renal disease (ESRD)","volume":"7","author":"Kim","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_165","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1681\/ASN.2012030281","article-title":"Protein-bound uremic toxins stimulate crosstalk between leukocytes and vessel wall","volume":"24","author":"Pletinck","year":"2013","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_166","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1093\/ndt\/gfl584","article-title":"P-cresylsulphate, the main in vivo metabolite of p-cresol, activates leucocyte free radical production","volume":"22","author":"Schepers","year":"2007","journal-title":"Nephrol. Dial. Transplant."},{"key":"ref_167","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.toxlet.2016.10.006","article-title":"p-Cresyl sulfate affects the oxidative burst, phagocytosis process, and antigen presentation of monocyte-derived macrophages","volume":"263","author":"Azevedo","year":"2016","journal-title":"Toxicol. Lett."},{"key":"ref_168","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.atherosclerosis.2008.08.014","article-title":"The kynurenines are associated with oxidative stress, inflammation and the prevalence of cardiovascular disease in patients with end-stage renal disease","volume":"204","author":"Pawlak","year":"2009","journal-title":"Atherosclerosis"},{"key":"ref_169","doi-asserted-by":"crossref","first-page":"19189","DOI":"10.1074\/jbc.M109.024042","article-title":"Kynurenic acid triggers firm arrest of leukocytes to vascular endothelium under flow conditions","volume":"284","author":"Barth","year":"2009","journal-title":"J. Biol. Chem."},{"key":"ref_170","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1159\/000320765","article-title":"Guanidino compounds as cause of cardiovascular damage in chronic kidney disease: An in vitro evaluation","volume":"30","author":"Schepers","year":"2010","journal-title":"Blood Purif."},{"key":"ref_171","doi-asserted-by":"crossref","unstructured":"Tain, Y.L., and Hsu, C.N. (2017). Toxic Dimethylarginines: Asymmetric Dimethylarginine (ADMA) and Symmetric Dimethylarginine (SDMA). Toxins (Basel), 9.","DOI":"10.3390\/toxins9030092"},{"key":"ref_172","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1053\/j.ajkd.2016.10.033","article-title":"Serum Asymmetric and Symmetric Dimethylarginine and Morbidity and Mortality in Hemodialysis Patients","volume":"70","author":"Shafi","year":"2017","journal-title":"Am. J. Kidney Dis."},{"key":"ref_173","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.1681\/ASN.V9101826","article-title":"Inhibition of calcitriol-induced monocyte CD14 expression by uremic toxins: Role of purines","volume":"9","author":"Glorieux","year":"1998","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_174","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1093\/ndt\/gfs454","article-title":"The uraemic toxin phenylacetic acid contributes to inflammation by priming polymorphonuclear leucocytes","volume":"28","author":"Cohen","year":"2013","journal-title":"Nephrol. Dial. Transplant."},{"key":"ref_175","doi-asserted-by":"crossref","first-page":"2636","DOI":"10.1093\/ndt\/gfq080","article-title":"Dinucleoside polyphosphates: Newly detected uraemic compounds with an impact on leucocyte oxidative burst","volume":"25","author":"Schepers","year":"2010","journal-title":"Nephrol. Dial. Transplant."},{"key":"ref_176","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1006\/bbrc.1996.1157","article-title":"Induction of apoptotic cell death by methylglyoxal and 3-deoxyglucosone in macrophage-derived cell lines","volume":"225","author":"Okado","year":"1996","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_177","doi-asserted-by":"crossref","first-page":"3096","DOI":"10.1093\/ndt\/gfn218","article-title":"Polymorphonuclear leukocyte injury by methylglyoxal and hydrogen peroxide: A possible pathological role for enhanced oxidative stress in chronic kidney disease","volume":"23","author":"Nakayama","year":"2008","journal-title":"Nephrol. Dial. Transplant."},{"key":"ref_178","doi-asserted-by":"crossref","first-page":"2177","DOI":"10.4049\/jimmunol.125.5.2177","article-title":"Immunoglobulin synthesis by neoplastic B lymphocytes: Free light chain synthesis as a marker of B cell differentiation","volume":"125","author":"Gordon","year":"1980","journal-title":"J. Immunol."},{"key":"ref_179","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.2215\/CJN.02290508","article-title":"Quantitative assessment of serum and urinary polyclonal free light chains in patients with chronic kidney disease","volume":"3","author":"Hutchison","year":"2008","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"ref_180","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1093\/ndt\/17.5.879","article-title":"Effect of dialysis on serum\/plasma levels of free immunoglobulin light chains in end-stage renal disease patients","volume":"17","author":"Cohen","year":"2002","journal-title":"Nephrol. Dial. Transplant."},{"key":"ref_181","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1681\/ASN.2006080821","article-title":"Efficient removal of immunoglobulin free light chains by hemodialysis for multiple myeloma: In vitro and in vivo studies","volume":"18","author":"Hutchison","year":"2007","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_182","first-page":"165","article-title":"Performance of hemodialysis with novel medium cut-off dialyzers","volume":"32","author":"Kirsch","year":"2017","journal-title":"Nephrol. Dial. Transplant."},{"key":"ref_183","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1681\/ASN.V661592","article-title":"Effect of immunoglobulin light chains from hemodialysis and continuous ambulatory peritoneal dialysis patients on polymorphonuclear leukocyte functions","volume":"6","author":"Cohen","year":"1995","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_184","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1046\/j.1365-2362.2003.01191.x","article-title":"Immunoglobulin light chains modulate polymorphonuclear leucocyte apoptosis","volume":"33","author":"Cohen","year":"2003","journal-title":"Eur. J. Clin. Invest."},{"key":"ref_185","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/1476-511X-7-29","article-title":"Isoforms of retinol binding protein 4 (RBP4) are increased in chronic diseases of the kidney but not of the liver","volume":"7","author":"Frey","year":"2008","journal-title":"Lipids Health Dis."},{"key":"ref_186","doi-asserted-by":"crossref","first-page":"9694","DOI":"10.1074\/jbc.M111.301721","article-title":"Increased unbound retinol-binding protein 4 concentration induces apoptosis through receptor-mediated signaling","volume":"287","author":"Chen","year":"2012","journal-title":"J. Biol. Chem."},{"key":"ref_187","doi-asserted-by":"crossref","first-page":"5103","DOI":"10.1128\/MCB.00820-12","article-title":"Retinol-binding protein 4 induces inflammation in human endothelial cells by an NADPH oxidase- and nuclear factor kappa B-dependent and retinol-independent mechanism","volume":"32","author":"Farjo","year":"2012","journal-title":"Mol. Cell. Biol."},{"key":"ref_188","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1111\/j.1365-2362.2004.01418.x","article-title":"Retinol binding protein isolated from acute renal failure patients inhibits polymorphonuclear leucocyte functions","volume":"34","author":"Cohen","year":"2004","journal-title":"Eur. J. Clin. Invest."},{"key":"ref_189","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1007\/s00005-008-0035-0","article-title":"Opiate abuse, innate immunity, and bacterial infectious diseases","volume":"56","author":"Wang","year":"2008","journal-title":"Arch. Immunol. Ther. Exp. (Warsz)"},{"key":"ref_190","first-page":"219","article-title":"Plasma met-enkephalin and leu-enkephalin in chronic renal failure","volume":"1","author":"Zoccali","year":"1987","journal-title":"Nephrol. Dial. Transplant."},{"key":"ref_191","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S0165-2478(98)00114-X","article-title":"Priming effect of met-enkephalin and beta-endorphin on chemiluminescence, chemotaxis and CD11b molecule expression on human neutrophils in vitro","volume":"67","author":"Pasnik","year":"1999","journal-title":"Immunol. Lett."},{"key":"ref_192","unstructured":"Wieder, L. (2018). Effects of Met-Enkephalin, Neuropeptide-Y and Endothelin-1 on Essential Functions of Polymorphonuclear Leukocytes (PMNLs). [Ph.D. Thesis, Medical University of Vienna]."},{"key":"ref_193","doi-asserted-by":"crossref","first-page":"E47","DOI":"10.1152\/ajpendo.00163.2004","article-title":"Hormonal responses to fasting and refeeding in chronic renal failure patients","volume":"288","author":"Deshmukh","year":"2005","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"ref_194","doi-asserted-by":"crossref","first-page":"2611","DOI":"10.1097\/01.ASN.0000089026.28617.33","article-title":"Prospective study of neuropeptide y as an adverse cardiovascular risk factor in end-stage renal disease","volume":"14","author":"Zoccali","year":"2003","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_195","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1111\/apha.12445","article-title":"The homeostatic role of neuropeptide Y in immune function and its impact on mood and behaviour","volume":"213","author":"Farzi","year":"2015","journal-title":"Acta Physiol. (Oxf.)"},{"key":"ref_196","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.jneuroim.2008.01.012","article-title":"Neuropeptide Y receptor-specifically modulates human neutrophil function","volume":"195","author":"Bedoui","year":"2008","journal-title":"J. Neuroimmunol."},{"key":"ref_197","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s00726-011-1185-7","article-title":"The intriguing mission of neuropeptide Y in the immune system","volume":"45","author":"Dimitrijevic","year":"2013","journal-title":"Amino Acids"},{"key":"ref_198","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1093\/oxfordjournals.ndt.a092132","article-title":"Endothelin in chronic renal failure","volume":"7","author":"Deray","year":"1992","journal-title":"Nephrol. Dial. Transplant."},{"key":"ref_199","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1139\/y11-116","article-title":"Endothelin-1 induces neutrophil recruitment in adaptive inflammation via TNFalpha and CXCL1\/CXCR2 in mice","volume":"90","author":"Zarpelon","year":"2012","journal-title":"Can. J. Physiol. Pharmacol."},{"key":"ref_200","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.lfs.2014.04.021","article-title":"Endothelin-1 and its role in the pathogenesis of infectious diseases","volume":"118","author":"Freeman","year":"2014","journal-title":"Life Sci."},{"key":"ref_201","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1038\/sj.bjp.0702593","article-title":"Endothelin-1 enhances neutrophil adhesion to human coronary artery endothelial cells: Role of ET(A) receptors and platelet-activating factor","volume":"127","author":"Zouki","year":"1999","journal-title":"Br. J. Pharmacol."},{"key":"ref_202","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/0006-291X(91)91461-K","article-title":"The biosynthesis of endothelin-1 by human polymorphonuclear leukocytes","volume":"174","author":"Sessa","year":"1991","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_203","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.regpep.2009.06.004","article-title":"Endothelin receptor A expression in human inflammatory cells","volume":"158","author":"Mencarelli","year":"2009","journal-title":"Regul. Pept."},{"key":"ref_204","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/S0006-291X(05)80061-0","article-title":"Endothelin-1 enhances superoxide generation of human neutrophils stimulated by the chemotactic peptide N-formyl-methionyl-leucyl-phenylalanine","volume":"173","author":"Ishida","year":"1990","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_205","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1053\/j.jrn.2011.10.029","article-title":"Adipokines as uremic toxins","volume":"22","author":"Teta","year":"2012","journal-title":"J. Ren. Nutr."},{"key":"ref_206","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1038\/oby.2008.607","article-title":"Innate immunity and adipocyte function: Ligand-specific activation of multiple Toll-like receptors modulates cytokine, adipokine, and chemokine secretion in adipocytes","volume":"17","author":"Kopp","year":"2009","journal-title":"Obes. (Silver Spring)"},{"key":"ref_207","doi-asserted-by":"crossref","first-page":"60","DOI":"10.4103\/jrms.JRMS_1115_17","article-title":"The complex effects of adipokines in the patients with kidney disease","volume":"23","author":"Vahdat","year":"2018","journal-title":"J. Res. Med. Sci."},{"key":"ref_208","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1038\/nrneph.2017.157","article-title":"Immunologic and endocrine functions of adipose tissue: Implications for kidney disease","volume":"14","author":"Zhu","year":"2018","journal-title":"Nat. Rev. Nephrol."},{"key":"ref_209","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1089\/jir.2019.0014","article-title":"Inflammation and Immunity: From an Adipocyte\u2019s Perspective","volume":"39","author":"Chan","year":"2019","journal-title":"J. Interferon Cytokine Res."},{"key":"ref_210","doi-asserted-by":"crossref","first-page":"3626","DOI":"10.1093\/ndt\/gfp405","article-title":"Human uraemic plasma stimulates release of leptin and uptake of tumour necrosis factor-alpha in visceral adipocytes","volume":"24","author":"Aminzadeh","year":"2009","journal-title":"Nephrol. Dial. Transplant."},{"key":"ref_211","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.biochi.2014.06.024","article-title":"Leptin as an uremic toxin: Deleterious role of leptin in chronic kidney disease","volume":"105","author":"Alix","year":"2014","journal-title":"Biochimie"},{"key":"ref_212","first-page":"2882","article-title":"Relationship between leptin and chronic inflammatory state in uremic patients","volume":"18","author":"Peng","year":"2014","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"ref_213","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.1093\/ndt\/gfq731","article-title":"Effect of leptin on polymorphonuclear leucocyte functions in healthy subjects and haemodialysis patients","volume":"26","author":"Cohen","year":"2011","journal-title":"Nephrol. Dial. Transplant."},{"key":"ref_214","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1007\/s00125-006-0173-z","article-title":"Macrophages in human visceral adipose tissue: Increased accumulation in obesity and a source of resistin and visfatin","volume":"49","author":"Curat","year":"2006","journal-title":"Diabetologia"},{"key":"ref_215","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.regpep.2009.05.002","article-title":"The expression of human resistin in different leucocyte lineages is modulated by LPS and TNFalpha","volume":"157","author":"Kunnari","year":"2009","journal-title":"Regul. Pept."},{"key":"ref_216","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/s40635-019-0257-y","article-title":"Resistin directly inhibits bacterial killing in neutrophils","volume":"7","author":"Miller","year":"2019","journal-title":"Intensive Care Med. Exp."},{"key":"ref_217","doi-asserted-by":"crossref","first-page":"3761","DOI":"10.4049\/jimmunol.181.6.3761","article-title":"Resistin inhibits essential functions of polymorphonuclear leukocytes","volume":"181","author":"Cohen","year":"2008","journal-title":"J. Immunol."},{"key":"ref_218","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1016\/j.bbamcr.2009.09.008","article-title":"Resistin is stored in neutrophil granules being released upon challenge with inflammatory stimuli","volume":"1793","author":"Bostrom","year":"2009","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_219","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1093\/cvr\/cvp278","article-title":"Resistin: A newly identified chemokine for human CD4-positive lymphocytes","volume":"85","author":"Walcher","year":"2010","journal-title":"Cardiovasc. Res."},{"key":"ref_220","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1038\/nrneph.2017.103","article-title":"Mechanisms and consequences of carbamoylation","volume":"13","author":"Delanghe","year":"2017","journal-title":"Nat. Rev. Nephrol."},{"key":"ref_221","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1681\/ASN.2012030254","article-title":"Protein carbamylation predicts mortality in ESRD","volume":"24","author":"Koeth","year":"2013","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_222","first-page":"882","article-title":"Urea-derived cyanate forms epsilon-amino-carbamoyl-lysine (homocitrulline) in leukocyte proteins in patients with end-stage renal disease on peritoneal dialysis","volume":"123","author":"Kraus","year":"1994","journal-title":"J. Lab. Clin. Med."},{"key":"ref_223","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.chembiol.2005.11.005","article-title":"Impact of carbamylation on type I collagen conformational structure and its ability to activate human polymorphonuclear neutrophils","volume":"13","author":"Jaisson","year":"2006","journal-title":"Chem. Biol."},{"key":"ref_224","doi-asserted-by":"crossref","first-page":"453","DOI":"10.5301\/JN.2011.8342","article-title":"Plasma protein carbonylation in chronic uremia","volume":"24","author":"Pavone","year":"2011","journal-title":"J. Nephrol."},{"key":"ref_225","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1056\/NEJM199109193251202","article-title":"Advanced glycosylation end products in patients with diabetic nephropathy","volume":"325","author":"Makita","year":"1991","journal-title":"N. Engl. J. Med."},{"key":"ref_226","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1681\/ASN.2014101047","article-title":"Uremic Toxicity of Advanced Glycation End Products in CKD","volume":"27","author":"Stinghen","year":"2016","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_227","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1161\/01.ATV.21.6.905","article-title":"Receptor for advanced glycation end products mediates inflammation and enhanced expression of tissue factor in vasculature of diabetic apolipoprotein E-null mice","volume":"21","author":"Kislinger","year":"2001","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_228","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1681\/ASN.V1261264","article-title":"Glucose-modified proteins modulate essential functions and apoptosis of polymorphonuclear leukocytes","volume":"12","author":"Cohen","year":"2001","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_229","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.1111\/j.1523-1755.2004.00961.x","article-title":"In vitro evidence for immune activating effect of specific AGE structures retained in uremia","volume":"66","author":"Glorieux","year":"2004","journal-title":"Kidney Int."},{"key":"ref_230","doi-asserted-by":"crossref","first-page":"9010","DOI":"10.1073\/pnas.87.22.9010","article-title":"Advanced protein glycosylation induces transendothelial human monocyte chemotaxis and secretion of platelet-derived growth factor: Role in vascular disease of diabetes and aging","volume":"87","author":"Kirstein","year":"1990","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_231","first-page":"36","article-title":"Advanced glycation end products stimulate tumor necrosis factor-alpha and interleukin-1 beta secretion by peritoneal macrophages in patients on continuous ambulatory peritoneal dialysis","volume":"8","author":"Rashid","year":"2006","journal-title":"Isr. Med. Assoc. J."},{"key":"ref_232","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1042\/BJ20080054","article-title":"Receptor for advanced glycation end-products (RAGE) modulates neutrophil adhesion and migration on glycoxidated extracellular matrix","volume":"416","author":"Toure","year":"2008","journal-title":"Biochem. J."},{"key":"ref_233","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1038\/nrneph.2010.54","article-title":"RAGE and the pathogenesis of chronic kidney disease","volume":"6","author":"Schmidt","year":"2010","journal-title":"Nat. Rev. Nephrol."},{"key":"ref_234","doi-asserted-by":"crossref","first-page":"S11","DOI":"10.1046\/j.1523-1755.63.s84.47.x","article-title":"Are advanced oxidation protein products potential uremic toxins?","volume":"63","author":"Gausson","year":"2003","journal-title":"Kidney Int. Suppl."},{"key":"ref_235","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1093\/ndt\/gfl007","article-title":"Respective role of uraemic toxins and myeloperoxidase in the uraemic state","volume":"21","author":"Gausson","year":"2006","journal-title":"Nephrol. Dial. Transplant."},{"key":"ref_236","doi-asserted-by":"crossref","first-page":"451","DOI":"10.4049\/jimmunol.167.1.451","article-title":"Serum proteins modified by neutrophil-derived oxidants as mediators of neutrophil stimulation","volume":"167","author":"Wolfel","year":"2001","journal-title":"J. Immunol."},{"key":"ref_237","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1016\/j.clinbiochem.2008.04.019","article-title":"The ability of HDL to inhibit VCAM-1 expression and oxidized LDL uptake is impaired in renal patients","volume":"41","author":"Jurek","year":"2008","journal-title":"Clin. Biochem."},{"key":"ref_238","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1681\/ASN.2008070734","article-title":"Oxidized LDL modulates apoptosis of regulatory T cells in patients with ESRD","volume":"20","author":"Meier","year":"2009","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_239","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.cca.2011.11.009","article-title":"Albumin modification and fragmentation in renal disease","volume":"413","author":"Donadio","year":"2012","journal-title":"Clin. Chim. Acta"},{"key":"ref_240","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1291\/hypres.28.973","article-title":"Oxidation and carboxy methyl lysine-modification of albumin: Possible involvement in the progression of oxidative stress in hemodialysis patients","volume":"28","author":"Mera","year":"2005","journal-title":"Hypertens Res."},{"key":"ref_241","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.tem.2010.10.001","article-title":"High density lipoprotein: it\u2019s not just about lipid transport anymore","volume":"22","author":"Gordon","year":"2011","journal-title":"Trends Endocrinol. Metab."},{"key":"ref_242","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1161\/CIRCULATIONAHA.111.066589","article-title":"Cholesterol efflux and atheroprotection: Advancing the concept of reverse cholesterol transport","volume":"125","author":"Rosenson","year":"2012","journal-title":"Circulation"},{"key":"ref_243","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1038\/nrcardio.2010.222","article-title":"HDL and cardiovascular disease: Atherogenic and atheroprotective mechanisms","volume":"8","author":"Navab","year":"2011","journal-title":"Nat. Rev. Cardiol."},{"key":"ref_244","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1194\/jlr.R039297","article-title":"Cardioprotective functions of HDLs","volume":"55","author":"Rye","year":"2014","journal-title":"J. Lipid Res."},{"key":"ref_245","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1097\/MOL.0000000000000555","article-title":"Emerging roles of HDL in immune function","volume":"29","author":"Creasy","year":"2018","journal-title":"Curr. Opin. Lipidol."},{"key":"ref_246","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.atherosclerosis.2011.06.045","article-title":"Emerging role of high density lipoproteins as a player in the immune system","volume":"220","author":"Norata","year":"2012","journal-title":"Atherosclerosis"},{"key":"ref_247","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.1093\/clinchem\/33.12.2195","article-title":"Flow-cytometric determination of high-density-lipoprotein binding sites on human leukocytes","volume":"33","author":"Schmitz","year":"1987","journal-title":"Clin. Chem."},{"key":"ref_248","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.1016\/S0022-2275(20)41894-2","article-title":"Apolipoprotein A-I decreases neutrophil degranulation and superoxide production","volume":"32","author":"Blackburn","year":"1991","journal-title":"J. Lipid Res."},{"key":"ref_249","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1161\/ATVBAHA.111.226258","article-title":"Neutrophil activation is attenuated by high-density lipoprotein and apolipoprotein A-I in in vitro and in vivo models of inflammation","volume":"31","author":"Murphy","year":"2011","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_250","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1161\/ATVBAHA.108.168690","article-title":"High-density lipoprotein reduces the human monocyte inflammatory response","volume":"28","author":"Murphy","year":"2008","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_251","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.lfs.2004.10.066","article-title":"Neutrophils activation can be diminished by apolipoprotein A-I","volume":"77","author":"Liao","year":"2005","journal-title":"Life Sci."},{"key":"ref_252","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1161\/CIRCULATIONAHA.117.032636","article-title":"Cholesterol Efflux Pathways Suppress Inflammasome Activation, NETosis, and Atherogenesis","volume":"138","author":"Westerterp","year":"2018","journal-title":"Circulation"},{"key":"ref_253","doi-asserted-by":"crossref","unstructured":"Spirig, R., Schaub, A., Kropf, A., Miescher, S., Spycher, M.O., and Rieben, R. (2013). Reconstituted high-density lipoprotein modulates activation of human leukocytes. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0071235"},{"key":"ref_254","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.2174\/0929867325666180530110543","article-title":"Biological consequences of dysfunctional HDL","volume":"26","author":"Pirillo","year":"2018","journal-title":"Curr. Med. Chem."},{"key":"ref_255","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.pharmthera.2012.12.001","article-title":"Inflammation alters HDL composition and function: Implications for HDL-raising therapies","volume":"137","author":"Marsche","year":"2013","journal-title":"Pharmacol. Ther."},{"key":"ref_256","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1111\/j.1365-2362.2010.02361.x","article-title":"The versatility of HDL: A crucial anti-inflammatory regulator","volume":"40","author":"Saemann","year":"2010","journal-title":"Eur. J. Clin. Invest."},{"key":"ref_257","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1093\/eurheartj\/ehx118","article-title":"Symmetric dimethylarginine, high-density lipoproteins and cardiovascular disease","volume":"38","author":"Zewinger","year":"2017","journal-title":"Eur. Heart J."},{"key":"ref_258","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1681\/ASN.2011070668","article-title":"Serum Amyloid A in Uremic HDL Promotes Inflammation","volume":"23","author":"Weichhart","year":"2012","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_259","doi-asserted-by":"crossref","unstructured":"Florens, N., Calzada, C., Lyasko, E., Juillard, L., and Soulage, C.O. (2016). Modified Lipids and Lipoproteins in Chronic Kidney Disease: A New Class of Uremic Toxins. Toxins (Basel), 8.","DOI":"10.3390\/toxins8120376"},{"key":"ref_260","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1093\/cvr\/cvs089","article-title":"High-density lipoprotein loses its anti-inflammatory capacity by accumulation of pro-inflammatory-serum amyloid A","volume":"94","author":"Tolle","year":"2012","journal-title":"Cardiovasc. Res."},{"key":"ref_261","doi-asserted-by":"crossref","unstructured":"Raupachova, J., Kopecky, C., and Cohen, G. (2019). High-Density Lipoprotein from Chronic Kidney Disease Patients Modulates Polymorphonuclear Leukocytes. Toxins (Basel), 11.","DOI":"10.3390\/toxins11020073"},{"key":"ref_262","first-page":"14","article-title":"Protective effects of hydrogen sulfide on chronic kidney disease by reducing oxidative stress, inflammation and apoptosis","volume":"17","author":"Askari","year":"2018","journal-title":"EXCLI J."},{"key":"ref_263","doi-asserted-by":"crossref","first-page":"385","DOI":"10.3389\/fphar.2016.00385","article-title":"The Role of Hydrogen Sulfide in Renal System","volume":"7","author":"Cao","year":"2016","journal-title":"Front. Pharmacol."},{"key":"ref_264","doi-asserted-by":"crossref","first-page":"S11","DOI":"10.1053\/j.jrn.2010.05.004","article-title":"Hydrogen Sulfide, the Third Gaseous Signaling Molecule With Cardiovascular Properties, Is Decreased in Hemodialysis Patients","volume":"20","author":"Perna","year":"2010","journal-title":"J. Renal Nutr."},{"key":"ref_265","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1038\/ki.2011.285","article-title":"Hydrogen sulfide increases after a single hemodialysis session","volume":"80","author":"Perna","year":"2011","journal-title":"Kidney Int."},{"key":"ref_266","doi-asserted-by":"crossref","unstructured":"Vigorito, C., Anishchenko, E., Mele, L., Capolongo, G., Trepiccione, F., Zacchia, M., Lombari, P., Capasso, R., Ingrosso, D., and Perna, A.F. (2019). Uremic Toxin Lanthionine Interferes with the Transsulfuration Pathway, Angiogenetic Signaling and Increases Intracellular Calcium. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20092269"},{"key":"ref_267","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.niox.2014.05.014","article-title":"Hydrogen sulfide and nitric oxide interactions in inflammation","volume":"41","author":"Fox","year":"2014","journal-title":"Nitric Oxide"},{"key":"ref_268","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1038\/sj.bjp.0706367","article-title":"Inhibition of endogenous hydrogen sulfide formation reduces the organ injury caused by endotoxemia","volume":"146","author":"Collin","year":"2005","journal-title":"Br. J. Pharmacol."},{"key":"ref_269","doi-asserted-by":"crossref","first-page":"L960","DOI":"10.1152\/ajplung.00388.2006","article-title":"Hydrogen sulfide acts as an inflammatory mediator in cecal ligation and puncture-induced sepsis in mice by upregulating the production of cytokines and chemokines via NF-kappaB","volume":"292","author":"Zhang","year":"2007","journal-title":"Am. J. Physiol. Lung Cell. Mol. Physiol."},{"key":"ref_270","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1038\/sj.bjp.0706014","article-title":"Role of hydrogen sulphide in haemorrhagic shock in the rat: Protective effect of inhibitors of hydrogen sulphide biosynthesis","volume":"143","author":"Mok","year":"2004","journal-title":"Br. J. Pharmacol."},{"key":"ref_271","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1038\/labinvest.3700391","article-title":"Hydrogen sulfide prevents apoptosis of human PMN via inhibition of p38 and caspase 3","volume":"86","author":"Rinaldi","year":"2006","journal-title":"Lab. Invest."},{"key":"ref_272","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1164\/rccm.200907-1145OC","article-title":"Hydrogen sulfide improves neutrophil migration and survival in sepsis via K+ATP channel activation","volume":"182","author":"Spiller","year":"2010","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_273","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1089\/ars.2011.4351","article-title":"Hydrogen sulfide: An endogenous mediator of resolution of inflammation and injury","volume":"17","author":"Wallace","year":"2012","journal-title":"Antioxid. Redox Signal."},{"key":"ref_274","doi-asserted-by":"crossref","first-page":"2118","DOI":"10.1096\/fj.06-6270fje","article-title":"Hydrogen sulfide is an endogenous modulator of leukocyte-mediated inflammation","volume":"20","author":"Zanardo","year":"2006","journal-title":"Faseb. J."},{"key":"ref_275","doi-asserted-by":"crossref","first-page":"14676","DOI":"10.1038\/s41598-018-33101-x","article-title":"Hydrogen sulfide limits neutrophil transmigration, inflamm.ation, and oxidative burst in lipopolysaccharide-induced acute lung injury","volume":"8","author":"Faller","year":"2018","journal-title":"Sci. Rep."}],"container-title":["Toxins"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6651\/12\/7\/439\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T09:47:41Z","timestamp":1760176061000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6651\/12\/7\/439"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,5]]},"references-count":275,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2020,7]]}},"alternative-id":["toxins12070439"],"URL":"https:\/\/doi.org\/10.3390\/toxins12070439","relation":{},"ISSN":["2072-6651"],"issn-type":[{"value":"2072-6651","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7,5]]}}}